MENU
ONCO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Onconetix (ONCO) Ownership - Who owns Onconetix?
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men’s health and oncology... Show more
Profile
Industry
N/A
Address
201 East Fifth Street
Phone
+1 513 620-4101
Employees
12
Web
https://www.onconetix.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.08M
P/E Ratio
N/A
Total Cash
341.5K
Projected Growth
N/A
Total Debt
10.12M
Revenue
1.87M
Risk (Beta)
3.46
Dividend Yield
N/A
Total Cash/Share
0.01
Total Debt/Equity
N/A
Revenue/Share
0.92 USD as % of share price
Fundamentals
ONCO
Capitalization
3.08M
P/E Ratio
N/A
Risk (Beta)
3.46
Dividend Yield
N/A
Total Cash
341K
Total Cash/Share
0.01
Total Debt
10.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.92%
Revenue
1.87M
ROE
N/A
Book Value
33.9M
P/B Ratio
0.36
Cash Flow
N/A
Earnings
-87.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
83
Current Ratio
0.06
Current Revenue Per Employee
33904.92
Dividends Per Share - Security
N/A
EBITDA
-49.74M
Float
N/A
Float - Current
N/A
Gross Income Margin
25.91
Revenue To Assets
-114.93
Shares Held By Institutions
256K
Shares Outstanding - Current
44.4M
Total Liabilities
20.9M
Total Volume MTD
N/A
Value
1
Gain YTD
-88.413
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
201 East Fifth Street
Phone
+1 513 620-4101
Employees
12
Web
https://www.onconetix.com